Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SKP1 Antikörper (AA 1-163)

SKP1 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7168550
  • Target Alle SKP1 Antikörper anzeigen
    SKP1 (S-Phase Kinase-Associated Protein 1 (SKP1))
    Bindungsspezifität
    • 15
    • 7
    • 7
    • 6
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-163
    Reaktivität
    • 54
    • 41
    • 39
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 62
    • 7
    Kaninchen
    Klonalität
    • 52
    • 17
    Polyklonal
    Konjugat
    • 32
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser SKP1 Antikörper ist unkonjugiert
    Applikation
    • 49
    • 26
    • 14
    • 13
    • 10
    • 9
    • 7
    • 4
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC)
    Kreuzreaktivität
    Human
    Aufreinigung
    Antigen Affinity Purified
    Immunogen
    Recombinant Human S-phase kinase-associated protein 1 protein (1-163AA)
    Isotyp
    IgG
    Top Product
    Discover our top product SKP1 Primärantikörper
  • Applikationshinweise
    Recommended dilution: IHC:1:20-1:200,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    SKP1 (S-Phase Kinase-Associated Protein 1 (SKP1))
    Andere Bezeichnung
    SKP1 (SKP1 Produkte)
    Synonyme
    EMC19 antikoerper, OCP-II antikoerper, OCP2 antikoerper, SKP1A antikoerper, TCEB1L antikoerper, p19A antikoerper, 15kDa antikoerper, 2610043E24Rik antikoerper, 2610206H23Rik antikoerper, SKP1 antikoerper, Tceb1l antikoerper, p19Skp1 antikoerper, Skp1a antikoerper, skp1a antikoerper, zgc:73186 antikoerper, ocp2 antikoerper, emc19 antikoerper, ocp-ii antikoerper, tceb1l antikoerper, ARABIDOPSIS SKP1 HOMOLOGUE 1 antikoerper, ASK1 antikoerper, ATSKP1 antikoerper, S phase kinase-associated protein 1 antikoerper, T4O12.17 antikoerper, T4O12_17 antikoerper, UFO INTERACTING PROTEIN 1 antikoerper, UIP1 antikoerper, ocp-2 antikoerper, S-phase kinase associated protein 1 antikoerper, S-phase kinase-associated protein 1 antikoerper, S-phase kinase-associated protein 1 pseudogene antikoerper, S-phase kinase-associated protein 1A antikoerper, S-phase kinase-associated protein 1 S homeolog antikoerper, S phase kinase-associated protein 1 antikoerper, SKP1 antikoerper, skp1 antikoerper, LOC100340043 antikoerper, Skp1a antikoerper, Skp1 antikoerper, skp1.S antikoerper
    Hintergrund

    Background: Essential component of the SCF (SKP1-CUL1-F-box protein) ubiquitin ligase complex, which mediates the ubiquitination of proteins involved in cell cycle progression, signal transduction and transcription. In the SCF complex, serves as an adapter that links the F-box protein to CUL1. The functional specificity of the SCF complex depends on the F-box protein as substrate recognition component. SCF(BTRC) and SCF(FBXW11) direct ubiquitination of CTNNB1 and participate in Wnt signaling. SCF(FBXW11) directs ubiquitination of phosphorylated NFKBIA. SCF(BTRC) directs ubiquitination of NFKBIB, NFKBIE, ATF4, SMAD3, SMAD4, CDC25A, FBXO5 and probably NFKB2. SCF(SKP2) directs ubiquitination of phosphorylated CDKN1B/p27kip and is involved in regulation of G1/S transition. SCF(SKP2) directs ubiquitination of ORC1, CDT1, RBL2, ELF4, CDKN1A, RAG2, FOXO1A, and probably MYC and TAL1. SCF(FBXW7) directs ubiquitination of cyclin E, NOTCH1 released notch intracellular domain (NICD), and probably PSEN1. SCF(FBXW2) directs ubiquitination of GCM1. SCF(FBXO32) directs ubiquitination of MYOD1. SCF(FBXO7) directs ubiquitination of BIRC2 and DLGAP5. SCF(FBXO33) directs ubiquitination of YBX1. SCF(FBXO11) directs ubiquitination of BCL6 and DTL but does not seem to direct ubiquitination of TP53. SCF(BTRC) mediates the ubiquitination of NFKBIA at \\\'Lys-21\\\' and \\\'Lys-22\\\', the degradation frees the associated NFKB1-RELA dimer to translocate into the nucleus and to activate transcription. SCF(CCNF) directs ubiquitination of CCP110. SCF(FBXL3) and SCF(FBXL21) direct ubiquitination of CRY1 and CRY2. SCF(FBXO9) direct ubiquitination of TTI1 and TELO2. SCF(FBXO10) direct ubiquitination of BCL2.

    Aliases: Cyclin A/CDK2 associated p19 antibody, Cyclin A/CDK2 associated protein p19 antibody, Cyclin-A/CDK2-associated protein p19 antibody, EMC19 antibody, MGC34403 antibody, OCP 2 antibody, OCP II antibody, OCP II protein antibody, OCP-2 antibody, OCP-II antibody, OCP2 antibody, OCPII antibody, Organ of Corti protein 2 antibody, Organ of Corti protein II antibody, OTTHUMP00000159379 antibody, OTTHUMP00000159380 antibody, OTTHUMP00000228275 antibody, OTTHUMP00000228276 antibody, OTTHUMP00000228278 antibody, OTTHUMP00000228279 antibody, OTTHUMP00000228281 antibody, p19A antibody, p19skp1 antibody, RNA polymerase II elongation factor like protein antibody, RNA polymerase II elongation factor like protein OCP2 antibody, RNA polymerase II elongation factor-like protein antibody, S phase kinase associated protein 1 antibody, S phase kinase associated protein 1A antibody, S phase kinase associated protein 1A p19A antibody, S-phase kinase-associated protein 1 antibody, SIII antibody, Skp 1 antibody, SKP 1A antibody, skp1 antibody, SKP1_HUMAN antibody, SKP1A antibody, TCEB1L antibody, Transcription Elongation Factor B 1 like antibody, Transcription elongation factor B antibody, Transcription elongation factor B SIII polypeptide 1 like antibody

    UniProt
    P63208
    Pathways
    Zellzyklus, Hedgehog Signalweg, Mitotic G1-G1/S Phases
Sie sind hier: